Alamdari NM et al. [12] 2020 (Iran) |
459 |
Retrospective cohort |
61.7 ± 11.8 |
320 (69.7%) |
214 (46.6%) |
119 (25.1%) |
185 (40.3%) |
117 (25.5%) |
An C et al. [13] 2020 (Korea) |
10,237 |
Retrospective cohort |
44.9 ± 19.7 |
4088 (39.9%) |
7090 (69.3%) |
1021 (10%) |
511 (5%) |
1074 (10.5%) |
Argenziano MG et al. [14] 2020 (USA) |
1000 |
Retrospective cohort |
62.6 ± 18.5 |
596 (59.6%) |
601 (60.1%) |
372 (37.2%) |
233 (23.3%) |
361 (36.1%) |
Ayed M et al. [15] 2020 (Kuwait) |
103 |
Retrospective cohort |
53.3 ± 14 |
88 (85.5%) |
36 (35%) |
40 (39.2%) |
12 (11.8%) |
10 (9.8%) |
Bifulco M et al. [16] 2020 (Italy) |
541 |
Retrospective cohort |
65 ± 11.3 |
341 (63%) |
273 (50.4%) |
130 (24%) |
143 (26.4%) |
117 (21.6%) |
Cariou B et al. [17] 2020 (France) |
1317 |
Retrospective cohort |
69.8 ± 13 |
855 (64.9%) |
1003 (77.2%) |
1317 (100%) |
140 (11.6%) |
627 (47.6%) |
Daniels LB et al. [18] 2020 (USA) |
170 |
Retrospective cohort |
59 ± 19 |
98 (57.6%) |
75 (44.1%) |
34 (20%) |
56 (32.9%) |
46 (27%) |
De Spiegeleer AD et al. [19] 2020 (Belgium) |
154 |
Retrospective cohort |
85.9 ± 7.2 |
51 (33.1%) |
39 (25.3%) |
28 (18.2%) |
N/A |
31 (20.1%) |
Dreher M et al. [20] 2020 (Germany) |
50 |
Retrospective cohort |
66.3 ± 13.3 |
33 (66%) |
35 (70%) |
29 (58%) |
7 (14%) |
18 (36%) |
Gupta A et al. [21] 2020 (USA) |
2626 |
Retrospective cohort |
62.3 ± 20 |
1497 (57%) |
1430 (54.4%) |
968 (36.8%) |
1052 (40%) |
876 (33.3%) |
Higuchi T et al. [22] 2020 (Japan) |
57 |
Retrospective cohort |
52.1 ± 25.5 |
32 (56.1%) |
16 (28.1%) |
13 (22.8%) |
5 (8.8%) |
12 (21.1%) |
Hippisley-Cox J et al. [23] 2020 (England) |
8,275,949 |
Prospective cohort |
48.4 ± 18.4 |
4,115,973 (49.7%) |
1,414,021 (17.1%) |
575,610 (6.9%) |
433,631 (5.24%) |
1,073,039 (12.9%) |
Ho F et al. [24] 2020 (England) |
285,817 |
Prospective cohort |
57.6 ± 8.4 |
131,589 (46%) |
N/A |
13,658 (4.7%) |
13,819 (4.8%) |
44,250 (15.4%) |
Holman N et al. [25] 2020 (England) |
3,138,410 |
Retrospective cohort |
65.8 ± 14.3 |
1,756,110 (55.9%) |
734,965 (23.4%) |
3,138,410 (100%) |
196,305 (6.2%) |
2,218,500 (70.6%) |
Huh K et al. [26] 2020 (Korea) |
65,149 |
Case-control |
48.3 ± 15.3 |
32,183 (49.4%) |
21,368 (32.8%) |
17,981 (27.6%) |
13,533 (20.7%) |
11,103 (17%) |
Inciardi RM et al. [27] 2020 (Italy) |
99 |
Retrospective cohort |
67 ± 12 |
80 (81%) |
63 (64%) |
30 (31%) |
53 (54%) |
25 (26%) |
Israel A et al. [28] 2020 (Israel) |
20,757 |
Retrospective cohort |
59 ± 19.1 |
10,473 (50.4%) |
8511 (41%) |
11,076 (53.3%) |
6873 (33.1%) |
937 (4.5%) |
Izzi-Engbeaya C et al. [29] 2020 |
889 |
Retrospective cohort |
65.8 ± 17.5 |
534 (60%) |
418 (47%) |
337 (38%) |
373 (42%) |
180.9 ± 99.8 |
Kibler M et al. [30] 2020 (France) |
702 |
Retrospective cohort |
82 ± 6.9 |
313 (44%) |
587 (83.6%) |
213 (30.3%) |
318 (45.3%) |
344 (50.2%) |
Lala A et al. [31] 2020 (USA) |
2736 |
Retrospective cohort |
66.4 ± 15.8 |
1630 (59.6%) |
1065 (38.9%) |
719 (26.3%) |
935 (34.1%) |
984 (36%) |
Luo P et al. [32] 2020 (China) |
283 |
Retrospective cohort |
64.5 ± 10 |
156 (55.1%) |
164 (57.9%) |
283 (100%) |
43 (15.1%) |
55 (19.4%) |
Maddaloni E et al. [33] 2020 (Italy) |
237 |
Case-control |
75 ± 12.5 |
151 (63.7%) |
N/A |
237 (100%) |
31 (13%) |
150 (63.2%) |
Masana L et al. [34] 2020 (Spain) |
2157 |
Retrospective cohort |
66.3 ± 17.7 |
1234 (57.3%) |
1081 (50.1%) |
501 (23.2%) |
620 (28.7%) |
581 (26.9%) |
McCarthy CP et al. [35] 2020 (USA) |
247 |
Retrospective cohort |
62.3 ± 19.2 |
143 (57.9%) |
128 (51.8%) |
68 (27.5%) |
114 (46.1%) |
107 (43.3%) |
Ramachandran P et al. [36] 2020 (USA) |
295 |
Retrospective cohort |
64.3 ± 14.8 |
162 (54.9%) |
209 (70.8%) |
132 (44.7%) |
45 (15.2%) |
114 (38.6%) |
Rodriguez-Nava G et al. [37] 2020 (USA) |
87 |
Retrospective cohort |
67 ± 12.5 |
56 (64.4%) |
N/A |
N/A |
N/A |
47 (54%) |
Saeed O et al. [38] 2020 (USA) |
4252 |
Retrospective cohort |
65 ± 16 |
2255 (53%) |
3060 (72%) |
2266 (53%) |
1111 (26%) |
1355 (31.8%) |
Song SL et al. [39] 2020 (USA) |
249 |
Retrospective cohort |
62.6 ± 17.7 |
142 (57%) |
122 (49%) |
83 (33.3%) |
70 (28.1%) |
123 (49.3%) |
Tan WYT et al. [40] 2020 (Singapore) |
717 |
Retrospective cohort |
40.6 ± 28.1 |
410 (57.2%) |
139 (19.3%) |
76 (10.6%) |
50 (6.9%) |
151 (21%) |
Ullah AZMD et al. [41] 2020 (England) |
15,586 |
Retrospective cohort |
57.1 ± 18.2 |
6840 (43.9%) |
10,167 (65.2%) |
6047 (38.8%) |
4421 (28.4%) |
5221 (33.5%) |
Vila-Corcoles A et al. [42] 2020 (Spain) |
34,936 |
Retrospective cohort |
70.9 ± 11.3 |
16,805 (48.1%) |
34,936 (100%) |
9829 (28.1%) |
10,097 (28.9%) |
11,328 (32.4%) |
Wang B et al. [43] 2020 (USA) |
58 |
Retrospective cohort |
67 ± 12.5 |
30 (52%) |
37 (64%) |
16 (28%) |
20 (34%) |
27 (47%) |
Yan H et al. [44] 2020 (China) |
49,245 |
Retrospective cohort |
49.9 ± 16.6 |
23,799 (48.3%) |
9985 (20.2%) |
2977 (6%) |
637 (2.1%) |
458 (1.5%) |
Zeng H et al. [45] 2020 (China) |
1031 |
Retrospective cohort |
60.3 ± 14.3 |
538 (52.2%) |
384 (37.2%) |
189 (18.3%) |
84 (8.1%) |
38 (3.6%) |
Zhang XJ et al. [46] 2020 (China) |
13,981 |
Retrospective cohort |
56.3 ± 16.2 |
6830 (48.8%) |
4860 (34.7%) |
2282 (16.3%) |
1171 (8.3%) |
1219 (8.7%) |